Today: 21 May 2026
Copper spikes near $13,000 a ton as London catches up after holiday, tariff fears bite
29 December 2025
2 mins read

Copper spikes near $13,000 a ton as London catches up after holiday, tariff fears bite

NEW YORK, December 29, 2025, 06:40 ET

  • Benchmark LME copper hit a record $12,960 a metric ton before easing back in holiday-thinned trade.
  • Prices in Shanghai and New York set records while London was shut, with a U.S. tariff review next year pulling metal toward U.S. warehouses.
  • China’s copper contract touched a record after news Beijing would rein in copper capacity growth in its next five-year plan.

Benchmark copper on the London Metal Exchange jumped to a record $12,960 a metric ton on Monday before paring gains to $12,415, up 2.1%, by 1030 GMT, as London trading resumed after a UK holiday.

The London market raced to catch up after being shut on Friday for Britain’s Boxing Day holiday, while copper in China and the United States rallied.

The sharp move matters for manufacturers because copper is used widely in wiring and industrial equipment and is a core input for power grids and renewable-energy infrastructure.

Analysts and traders have also pointed to trade dislocations linked to possible U.S. import tariffs, which have encouraged shipments of metal into the United States and tightened supply elsewhere.

“Comex led on Boxing Day,” said Robert Montefusco at broker Sucden Financial, referring to the U.S. copper market’s rally while London was closed. Business Recorder

U.S. Comex copper futures jumped to $5.8395 per lb on Friday, surpassing a record touched on July 23 when a planned date for U.S. tariffs approached, Reuters reported.

Reuters said U.S. tariffs imposed this year did not affect refined copper, but the decision will be revisited next year, prompting a fresh flow of copper into the United States to capture higher prices there.

That stock build has tightened markets elsewhere, while mine disruptions have led many analysts to forecast copper deficits next year, Reuters reported.

Copper on the LME is up about 41% for the year, supported by worries about shortages, a weaker dollar and a broader “risk-on” mood — stronger appetite for risk — across markets, according to Reuters. Business Recorder

The Financial Times reported copper is on track for its largest annual rise in more than a decade, after prices pushed above $12,000 a ton in December as the year-end rally intensified.

Demand is rising with the build-out of wind and solar power, electrification of vehicles and a boom in data centers that power artificial intelligence, while ageing mines are becoming less productive and new mines are costly and slow to develop, the Financial Times said.

The newspaper also said sustained high prices could push some manufacturers toward cheaper substitutes and hit less essential demand such as decarbonisation — cutting carbon emissions.

Copper stocks in Comex warehouses have reached a record 400,000 tonnes, while LME inventories have fallen, especially in Europe, the Financial Times reported, highlighting how the U.S. draw has reshaped physical supply.

Bloomberg said copper has gained more than 15% in December as investors bet a rush to get metal into the United States ahead of possible import tariffs will force buyers elsewhere to pay more.

In China, the most-active copper contract on the Shanghai Futures Exchange touched a record 102,660 yuan a ton and ended daytime trading at 98,860 yuan ($14,105.33), up 0.8%, after news China would rein in copper capacity growth in its next five-year plan, Reuters reported.

Other base metals mostly rose, with LME aluminium edging up to $2,963.50 a ton and zinc gaining to $3,112, while tin slipped to $42,600, Reuters said.

A Forex.com note dated Dec. 28 flagged copper as a trade to watch for 2026, as the market looks ahead to next year’s tariff decisions and an increasingly tight supply picture.

Stock Market Today

  • CyberTech Systems Earnings Raise Cash Flow Concerns Amid Market Stability
    May 20, 2026, 8:56 PM EDT. CyberTech Systems and Software Limited (NSE:CYBERTECH) posted earnings that met market expectations but revealed an accrual ratio of 0.53, indicating weaker free cash flow relative to profit. This financial metric, which measures non-cash earnings, signals potential challenges for upcoming profits as free cash flow of ₹76 million lagged behind reported profit of ₹304.3 million for the year ending March 2026. Despite a 28% annual growth in earnings per share (EPS) over three years, the decline in cash conversion may raise investor caution. The company's accrual ratio improved last year, suggesting the current shortfall could be temporary, but shareholders are advised to monitor cash flow trends closely against profitability for a clearer outlook.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
D-Wave stock slides into year-end as quantum peers retreat in thin trade
Previous Story

D-Wave stock slides into year-end as quantum peers retreat in thin trade

Tesla drops in premarket as supplier slashes battery deal from $2.9 bln to $7,386
Next Story

Tesla drops in premarket as supplier slashes battery deal from $2.9 bln to $7,386

Go toTop